CRGX(Delisted)
CARGO Therapeutics·NASDAQ
--
--(--)
CARGO Therapeutics (CRGX) Financial Statements
CARGO Therapeutics (CRGX) Cash Flow Statement
During Q1 2024, CARGO Therapeutics (CRGX) generated -30.15M in cash flow from operating activities, -293.96M from investing activities, and -104.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2023 | Q1,2024 | TTM |
|---|
Start Date | Jan 1, 2023 | Jan 1, 2024 | -- |
End Date | Mar 31, 2023 | Mar 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -14.06M -- | -30.15M -114.36% | -- -- |
Depreciation and Amortization | 470.00K -- | 1.30M +176.81% | -- -- |
Change in Working Capital | -20.00K -- | 2.09M +10530.00% | -- -- |
Net Cash Flows from Investing Activities | -619.00K -- | -293.96M -47388.85% | -- -- |
Purchase of PPE and Intangible Assets | 561.00K -- | 1.29M +129.77% | -- -- |
Increase in Investments | -- -- | 292.34M -- | -- -- |
Net Cash Flows from Financing Activities | 71.58M -- | -104.00K -100.15% | -- -- |
Change in Capital Stock | 68.08M -- | -- -- | -- -- |
Increase in Capital Stock | 68.08M -- | -- -- | -- -- |
Net Increase in Cash and Cash Equivalents | 56.89M -- | -324.21M -669.85% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 1.87M -- | 406.30M +21604.01% | -- -- |
Cash and Cash Equivalents at End of Period | 58.77M -- | 82.09M +39.70% | -- -- |
You can ask Aime
No Data
